AGT Newsletter Volume 6
NEWSLETTER VOL. 6 AGT’s progress over the first half of 2018 has been tremendous: six patents granted, major advances in all of its key projects: HIV, PKU and immuno-oncology, substantial momentum on socia...
AGT Newsletter Volume 5
End of year wrap-up Q4, 2017 Newsletter AGT is in position for key milestones and success in 2018. 2017 brought attention to the industry and particularly to AGT. We raised nearly $8M (approximately double the p...
AGT Newsletter Volume 4
AGT IN THE SPOTLIGHT American Gene Technologies International CEO, Jeff Galvin, is increasingly in demand for his thought leadership in addition to his vision for AGT. Jeff was invited to deliver the closing pre...
AGT Newsletter Volume 3
AGT CONTINUES TO GROW ITS TEAM AND RESOURCES INTERNALLY AND EXTERNALLY C. Neil Lyons AGT is announcing the appointment of C. Neil Lyons as Executive Vice President and Chief Financial Officer. Neil brings more t...
